Chronic myeloid leukemia treatment and human immunodeficiency virus infection
Gespeichert in:
| Veröffentlicht in: | Revista clínica espanõla (English edition) 2014-05, Vol.214 (4), p.231 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 4 |
| container_start_page | 231 |
| container_title | Revista clínica espanõla (English edition) |
| container_volume | 214 |
| creator | Campillo-Recio, D Perez-Rodriguez, L Yebra, E Cervero-Jimenez, M |
| description | |
| doi_str_mv | 10.1016/j.rce.2014.01.025 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_24564991</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>24564991</sourcerecordid><originalsourceid>FETCH-LOGICAL-p108t-2c468204e413119e816cff547f55ed86dbec6d54b6d4d5b3d0ab99a98432b9903</originalsourceid><addsrcrecordid>eNo1j8tKxDAUQIMgzjDOB7iR_EDrvWmSSZZSfMGIG10PaXLLZGzS0ocwf6-grs5ZHTiM3SCUCKjvTuXoqRSAsgQsQagLthZCycKYnVyx7TSdAAAFWqXhiq2EVFpai2v2Wh_HPkfP05m6Pgbe0fJJKTo-j-TmRHnmLgd-XJLLPKa05D5QG32k7M_8K47LxGNuyc-xz9fssnXdRNs_btjH48N7_Vzs355e6vt9MSCYuRBeaiNAksQK0ZJB7dtWyV2rFAWjQ0NeByUbHWRQTRXANdY6a2QlfgSqDbv97Q5LkygchjEmN54P_1_VN-TDUEA</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Chronic myeloid leukemia treatment and human immunodeficiency virus infection</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Campillo-Recio, D ; Perez-Rodriguez, L ; Yebra, E ; Cervero-Jimenez, M</creator><creatorcontrib>Campillo-Recio, D ; Perez-Rodriguez, L ; Yebra, E ; Cervero-Jimenez, M</creatorcontrib><identifier>EISSN: 2254-8874</identifier><identifier>DOI: 10.1016/j.rce.2014.01.025</identifier><identifier>PMID: 24564991</identifier><language>spa</language><publisher>Spain</publisher><subject>Adult ; Anti-HIV Agents - adverse effects ; Anti-HIV Agents - therapeutic use ; Antineoplastic Agents - adverse effects ; Antineoplastic Agents - therapeutic use ; Benzamides - adverse effects ; Benzamides - therapeutic use ; Drug Interactions ; HIV Infections - complications ; HIV Infections - drug therapy ; Humans ; Imatinib Mesylate ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy ; Male ; Piperazines - adverse effects ; Piperazines - therapeutic use ; Protein Kinase Inhibitors - adverse effects ; Protein Kinase Inhibitors - therapeutic use ; Pyrimidines - adverse effects ; Pyrimidines - therapeutic use ; Treatment Outcome</subject><ispartof>Revista clínica espanõla (English edition), 2014-05, Vol.214 (4), p.231</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24564991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Campillo-Recio, D</creatorcontrib><creatorcontrib>Perez-Rodriguez, L</creatorcontrib><creatorcontrib>Yebra, E</creatorcontrib><creatorcontrib>Cervero-Jimenez, M</creatorcontrib><title>Chronic myeloid leukemia treatment and human immunodeficiency virus infection</title><title>Revista clínica espanõla (English edition)</title><addtitle>Rev Clin Esp (Barc)</addtitle><subject>Adult</subject><subject>Anti-HIV Agents - adverse effects</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Benzamides - adverse effects</subject><subject>Benzamides - therapeutic use</subject><subject>Drug Interactions</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>Humans</subject><subject>Imatinib Mesylate</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</subject><subject>Male</subject><subject>Piperazines - adverse effects</subject><subject>Piperazines - therapeutic use</subject><subject>Protein Kinase Inhibitors - adverse effects</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Pyrimidines - adverse effects</subject><subject>Pyrimidines - therapeutic use</subject><subject>Treatment Outcome</subject><issn>2254-8874</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j8tKxDAUQIMgzjDOB7iR_EDrvWmSSZZSfMGIG10PaXLLZGzS0ocwf6-grs5ZHTiM3SCUCKjvTuXoqRSAsgQsQagLthZCycKYnVyx7TSdAAAFWqXhiq2EVFpai2v2Wh_HPkfP05m6Pgbe0fJJKTo-j-TmRHnmLgd-XJLLPKa05D5QG32k7M_8K47LxGNuyc-xz9fssnXdRNs_btjH48N7_Vzs355e6vt9MSCYuRBeaiNAksQK0ZJB7dtWyV2rFAWjQ0NeByUbHWRQTRXANdY6a2QlfgSqDbv97Q5LkygchjEmN54P_1_VN-TDUEA</recordid><startdate>201405</startdate><enddate>201405</enddate><creator>Campillo-Recio, D</creator><creator>Perez-Rodriguez, L</creator><creator>Yebra, E</creator><creator>Cervero-Jimenez, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>201405</creationdate><title>Chronic myeloid leukemia treatment and human immunodeficiency virus infection</title><author>Campillo-Recio, D ; Perez-Rodriguez, L ; Yebra, E ; Cervero-Jimenez, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p108t-2c468204e413119e816cff547f55ed86dbec6d54b6d4d5b3d0ab99a98432b9903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Anti-HIV Agents - adverse effects</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Benzamides - adverse effects</topic><topic>Benzamides - therapeutic use</topic><topic>Drug Interactions</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>Humans</topic><topic>Imatinib Mesylate</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</topic><topic>Male</topic><topic>Piperazines - adverse effects</topic><topic>Piperazines - therapeutic use</topic><topic>Protein Kinase Inhibitors - adverse effects</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Pyrimidines - adverse effects</topic><topic>Pyrimidines - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Campillo-Recio, D</creatorcontrib><creatorcontrib>Perez-Rodriguez, L</creatorcontrib><creatorcontrib>Yebra, E</creatorcontrib><creatorcontrib>Cervero-Jimenez, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Revista clínica espanõla (English edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Campillo-Recio, D</au><au>Perez-Rodriguez, L</au><au>Yebra, E</au><au>Cervero-Jimenez, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic myeloid leukemia treatment and human immunodeficiency virus infection</atitle><jtitle>Revista clínica espanõla (English edition)</jtitle><addtitle>Rev Clin Esp (Barc)</addtitle><date>2014-05</date><risdate>2014</risdate><volume>214</volume><issue>4</issue><spage>231</spage><pages>231-</pages><eissn>2254-8874</eissn><cop>Spain</cop><pmid>24564991</pmid><doi>10.1016/j.rce.2014.01.025</doi></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 2254-8874 |
| ispartof | Revista clínica espanõla (English edition), 2014-05, Vol.214 (4), p.231 |
| issn | 2254-8874 |
| language | spa |
| recordid | cdi_pubmed_primary_24564991 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Adult Anti-HIV Agents - adverse effects Anti-HIV Agents - therapeutic use Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Benzamides - adverse effects Benzamides - therapeutic use Drug Interactions HIV Infections - complications HIV Infections - drug therapy Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Male Piperazines - adverse effects Piperazines - therapeutic use Protein Kinase Inhibitors - adverse effects Protein Kinase Inhibitors - therapeutic use Pyrimidines - adverse effects Pyrimidines - therapeutic use Treatment Outcome |
| title | Chronic myeloid leukemia treatment and human immunodeficiency virus infection |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T00%3A13%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20myeloid%20leukemia%20treatment%20and%20human%20immunodeficiency%20virus%20infection&rft.jtitle=Revista%20cl%C3%ADnica%20espan%C3%B5la%20(English%20edition)&rft.au=Campillo-Recio,%20D&rft.date=2014-05&rft.volume=214&rft.issue=4&rft.spage=231&rft.pages=231-&rft.eissn=2254-8874&rft_id=info:doi/10.1016/j.rce.2014.01.025&rft_dat=%3Cpubmed%3E24564991%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/24564991&rfr_iscdi=true |